Application of real-world effectiveness outcomes of upadacitinib to Canadian treat-to-target criteria in atopic dermatitis
A retrospective multicenter analysis of 1-year data.
Waked J, Sood S, Rankin BD, Rimke A, Abduelmula A, Georgakopoulos JR, Maliyar K, Leung F, Devani AR, Yeung J, Prajapati VH
Journal of the American Academy of DermatologyIn the feed 29 Jul 2026, published online 29 Jul 2026, issue 2026 Jul 29, added to PubMed 29 Jul 2026
Topics: Atopic dermatitis & eczemaJAK inhibitors & other targeted pills
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42526811 · DOI 10.1016/j.jaad.2026.07.082